Artiva Biotherapeutics (ARTV) Equity Ratio: 2023-2025
Historic Equity Ratio for Artiva Biotherapeutics (ARTV) over the last 2 years, with Sep 2025 value amounting to 0.87.
- Artiva Biotherapeutics' Equity Ratio fell 2.57% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year decrease of 2.57%. This contributed to the annual value of 0.89 for FY2024, which is 157.78% up from last year.
- Artiva Biotherapeutics' Equity Ratio amounted to 0.87 in Q3 2025, which was down 1.34% from 0.88 recorded in Q2 2025.
- Artiva Biotherapeutics' Equity Ratio's 5-year high stood at 0.89 during Q3 2024, with a 5-year trough of -2.52 in Q2 2024.
- Its 3-year average for Equity Ratio is 0.05, with a median of 0.88 in 2025.
- As far as peak fluctuations go, Artiva Biotherapeutics' Equity Ratio surged by 157.78% in 2024, and later fell by 2.57% in 2025.
- Artiva Biotherapeutics' Equity Ratio (Quarterly) stood at -1.54 in 2023, then soared by 157.78% to 0.89 in 2024, then fell by 2.57% to 0.87 in 2025.
- Its Equity Ratio was 0.87 in Q3 2025, compared to 0.88 in Q2 2025 and 0.88 in Q1 2025.